Amvuttra यूरोपीय संघ - लातवियाई - EMA (European Medicines Agency)

amvuttra

alnylam netherlands b.v. - vutrisiran sodium - amyloid neuropathies, familial - other nervous system drugs - treatment of hereditary transthyretin-mediated amyloidosis (hattr amyloidosis) in adult patients with stage 1 or stage 2 polyneuropathy.

Pedmarqsi यूरोपीय संघ - लातवियाई - EMA (European Medicines Agency)

pedmarqsi

fennec pharmaceuticals (eu) limited - nātrija tiosulfāts - ear diseases; ototoxicity - visi pārējie terapeitiskie produkti - pedmarqsi is indicated for the prevention of ototoxicity induced by cisplatin chemotherapy in patients 1 month to < 18 years of age with localised, non-metastatic, solid tumours.